Table 1.
Clinical characteristics and ECMO outcomes for critically ill COVID-19 patients (N = 12)
Variables | Mean (SD) | Range | n | % |
---|---|---|---|---|
Age (years) | 50.9 (13.5) | 35–76 | ||
Gender (male) | 11 | 91.7 | ||
Comorbidities | ||||
Hypertension | 1 | 8.3 | ||
Heart disease | 1 | 8.3 | ||
Diabetes | 1 | 8.3 | ||
Hyperthyroidism | 1 | 8.3 | ||
Key reason for ICU admittance | ||||
Dyspnea | 11 | 91.7 | ||
Fever | 10 | 83.3 | ||
Coma | 1 | 8.3 | ||
Treatment type | ||||
ECMO | 12 | 100 | ||
Mechanical ventilation | 12 | 100 | ||
Antibiotic treatment | 12 | 100 | ||
Antiviral therapy | 12 | 100 | ||
Glucocorticoid therapy | 10 | 83.3 | ||
Supportive therapy based on symptoms | 12 | 100 | ||
Duration of ECMO use (days) | 11.3 (7.8) | 3–28 | ||
ECMO prognosis | ||||
Improving without ECMO | 3 | 25.0 | ||
Still alive with ECMO but two with coma | 4 | 33.3 | ||
Dying | 5 | 41.7 |
Abbreviations: ECMO extracorporeal membrane oxygenation, ICU intensive care unit